Pristimerin Overcomes Adriamycin Resistance in Breast Cancer Cells Through Suppressing Akt Signaling

Oncology Letters - Greece
doi 10.3892/ol.2016.4335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt

Journal of Cancer
Oncology
2011English

Zoledronic Acid Overcomes Adriamycin Resistance in Acute Myeloid Leukemia Cells by Promoting Apoptosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Cancer Research
Cancer ResearchOncology
2011English

Retraction: Ramentaceone, a Naphthoquinone Derived From Drosera Sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2019English

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

AKT Signaling in ERBB2-amplified Breast Cancer

Pharmacology and Therapeutics
Pharmacology
2016English

FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells

Oncology Letters
Cancer ResearchOncology
2015English

Interfering Cellular Lactate Homeostasis Overcomes Taxol Resistance of Breast Cancer Cells Through the microRNA-124-mediated Lactate Transporter (MCT1) Inhibition

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway

Biology Open
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy